Patent ID: 11857595
Assignee: AMRYT ENDO, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treating acromegaly in a subject, the method comprising:
a) orally administering to the subject at least one dosage form comprising octreotide, wherein the subject is administered an H2-receptor antagonist or an antacid;
b) monitoring IGF-1 and clinical symptoms or biochemical and symptomatic response of the subject; and
c) if IGF-1 is not normal and clinical symptoms are not controlled or biochemical and symptomatic response is not maintained, then increasing the total dose of oral octreotide administered to the subject;
wherein the dosage form comprises:
a composition comprising a suspension which is an admixture of a hydrophobic medium and a solid form,
wherein the solid form comprises: a therapeutically effective amount of octreotide and a medium chain fatty acid salt, wherein the composition comprises 12% to 18% by weight of the medium chain fatty acid salt.